CN104042957A - Traditional Chinese medicine (TCM) composition for treating prostatitis - Google Patents

Traditional Chinese medicine (TCM) composition for treating prostatitis Download PDF

Info

Publication number
CN104042957A
CN104042957A CN201410287952.6A CN201410287952A CN104042957A CN 104042957 A CN104042957 A CN 104042957A CN 201410287952 A CN201410287952 A CN 201410287952A CN 104042957 A CN104042957 A CN 104042957A
Authority
CN
China
Prior art keywords
parts
chinese medicine
herba
radix
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201410287952.6A
Other languages
Chinese (zh)
Inventor
姜丽莎
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN201410287952.6A priority Critical patent/CN104042957A/en
Publication of CN104042957A publication Critical patent/CN104042957A/en
Pending legal-status Critical Current

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The invention relates to a traditional Chinese medicine (TCM) composition for treating prostatitis. The composition is prepared from the following TCM raw materials in parts by weight: 10-40 parts of honeysuckle, 5-10 parts of akebia stem, 5-20 parts of polygonum aviculare, 10-30 parts of plantain seed, 5-20 parts of lilac pink herb, 10-30 parts of weeping forsythia capsule, 5-25 parts of oriental waterplantain rhizome, 5-20 parts of bamboo leaves, 10-40 parts of poria, 5-20 parts of tree peony root bark, 10-40 parts of salvia miltiorrhiza, 5-25 parts of cape jasmine fruit, 10-40 parts of talcum, 10-30 parts of rhizoma corydalis, 10-40 parts of dahurian angelica root, 5-20 parts of red peony root, 20-50 parts of spreading hedyotis herb, 10-40 parts of barbated skullcup herb and 5-10 parts of liquorice. The TCM composition has the functions of strengthening the spleen and stomach, clearing heat and expelling dampness, activating blood circulation to dissipate blood stasis, inducing diuresis for treating stranguria and benefiting qi to relieve pain, has obvious curative effects on prostatitis, and has reliable effects.

Description

One is treated prostatitic Chinese medicine composition
Technical field
Pharmaceutical product, the especially one of not the determining structure that the present invention relates to a kind of traditional herbal medicines are treated prostatitic Chinese medicine composition.
Background technology
Prostatitis is commonly encountered diseases, the frequently-occurring disease of male's accessory sex gland, prostatitis is not an independently disease, but a series of syndromes of being not only related but also having differed from one another, taking antibacterial infection as commonly encountered diseases because of, taking dribble of urine, cloudy urine, lower abdominal distention pain, urethra causalgia as main clinical manifestation.Prostatitis can be divided into prostatitis, congestion of prostate, prostatic hyperplasia and the prostatodynia that non-specific bacterial prostatitis, idiopathic bacterial prostatitis (claiming again prostatosis), specific prostatitis (being caused by gonococcus, tulase, fungus, parasite etc.), nonspecific granulomatous prostatitis, other pathogen (as virus, mycoplasma, chlamydia etc.) cause.At present, treatment prostatitis adopts antibiotics taking symptomatic treatment as main Western medicine mostly.Adopt western medicine to exist and cure the symptoms, not the disease, the course for the treatment of is long, general effect is little significant not enough.
Motherland's medical science thinks that prostatitis belongs to categories such as " strangurias ", many, polyphagia rich and fatty diet excessively fond of drinking because of being addicted to drink and pungent thing, and impairing the spleen and stomach, dysfunction of the spleen in transportation, poly-humidogene heat, due to the smart chamber of damp invasion of lower energizer.
According to theory of Chinese medical science, for prostatitic pathogeny, adopt the method for the treatment of of invigorating the spleen and regulating the stomach, clearing heat and expelling damp, promoting blood circulation to remove blood stasis, inducing diuresis for treating stranguria syndrome, promoting the circulation of QI pain relieving, carry out dialectical composition of prescription, to reach the object for the treatment of both the principal and secondary aspects of a disease.
Summary of the invention
In prior art, treat in order to overcome the deficiency that prostatitis exists, the invention provides a kind of prepare easy, cost is low, the prostatitic Chinese medicine composition for the treatment of evident in efficacy, that have no side effect.
The technical solution adopted for the present invention to solve the technical problems is: one is treated prostatitic Chinese medicine composition, it is characterized in that: its raw material of Chinese medicine and weight portion proportioning are: Flos Lonicerae 10-40 part, Caulis Akebiae 5-10 part, Herba Polygoni Avicularis 5-20 part, Semen Plantaginis 10-30 part, Herba Dianthi 5-20 part, Fructus Forsythiae 10-30 part, Rhizoma Alismatis 5-25 part, Folium Bambusae 5-20 part, Poria 10-40 part, Cortex Moutan 5-20 part, Radix Salviae Miltiorrhizae 10-40 part, Fructus Gardeniae 5-25 part, Talcum 10-40 part, Rhizoma Corydalis 10-30 part, Radix Angelicae Dahuricae 10-40 part, Radix Paeoniae Rubra 5-20 part, Hedyotidis Diffusae 20-50 part, Herba Scutellariae Barbatae 10-40 part, Radix Glycyrrhizae 5-10 part.
The preferred technical solution of the present invention is: one is treated prostatitic Chinese medicine composition, it is characterized in that: its raw material of Chinese medicine and weight portion proportioning are: 30 parts of Flos Loniceraes, 6 parts of Caulis Akebiaes, 10 parts of Herba Polygoni Avicularis, 20 parts of Semen Plantaginiss, 10 parts of Herba Dianthis, 20 parts of Fructus Forsythiaes, 15 parts of Rhizoma Alismatis, 10 parts, Folium Bambusae, 30 parts of Poria, 12 parts of Cortex Moutans, 30 parts of Radix Salviae Miltiorrhizaes, 15 parts of Fructus Gardeniaes, 30 parts, Talcum, 20 parts of Rhizoma Corydalis, 30 parts of the Radixs Angelicae Dahuricae, 10 parts of Radix Paeoniae Rubra, 40 parts of Hedyotidis Diffusaes, 30 parts of Herba Scutellariae Barbataes, 6 parts, Radix Glycyrrhizae.
Chinese medicine composition of the present invention is under Traditional Chinese medical theory and clinical experience guidance, selected medicament composing prescription.In Chinese medicine composition of the present invention: Flos Lonicerae has effect of heat-clearing and toxic substances removing, wind-heat dissipating; Caulis Akebiae has effect of pathogenic fire purging row water, promoting blood circulation, the stimulating milk secretion of stimulating the menstrual flow; Herba Polygoni Avicularis has inducing diuresis for treating stranguria syndrome, parasite killing, antipruritic effect; Semen Plantaginis has effect of relieving stranguria by diuresis, eliminating dampness by diuresis antidiarrheal, liver heat removing and eyesight improving, removing heat-phlegm; Herba Dianthi has effect that inducing diuresis for treating stranguria syndrome, removing blood stasis stimulate the menstrual flow; Fructus Forsythiae has effect of heat-clearing and toxic substances removing, mass dissipating and swelling eliminating; Rhizoma Alismatis has promoting diuresis to eliminate damp pathogen, treating stranguria effect expels the heat-evil; Folium Bambusae has clearing heat and relieving fidgetness, effect of the diuresis of promoting the production of body fluid; Poria has benefiting vital QI for tranquillizing, invigorating the spleen and regulating the stomach, dispels effect damp and hot, row water stopping leak; Cortex Moutan has effect of clearing away heat and cooling blood, promoting blood circulation to remove blood stasis; Radix Salviae Miltiorrhizae has effect of promoting blood flow to regulate menstruation, stasis-dispelling and pain-killing, removing heat from blood eliminating carbuncle, the relieving restlessness that clears away heart-fire, nourishing blood to tranquillize the mind; Fructus Gardeniae has effect of pathogenic fire purging relieving restlessness, clearing away heat-damp and promoting diuresis, removing pathogenic heat from blood and toxic substance from the body; Talcum has effect of inducing diuresis for treating stranguria syndrome, clearing away summer-heat, damp eliminating sore; Rhizoma Corydalis has effect of promoting blood circulation to remove blood stasis, promoting the circulation of QI pain relieving; The Radix Angelicae Dahuricae has effect of the cold expelling that induces sweat, expelling pathogenic wind and restoring the functions of orifices in face, promoting blood circulation and stopping pain, dampness leukorrhagia stopping, detumescence and apocenosis; Radix Paeoniae Rubra has effect of clearing away heat and cooling blood, eliminating stasis to stop pain; Hedyotidis Diffusae has effect of heat-clearing and toxic substances removing, inducing diuresis to remove edema, promoting blood circulation and stopping pain; Herba Scutellariae Barbatae has effect of heat-clearing and toxic substances removing, dissipating blood stasis hemostasis, subduing swelling and relieving pain; Radix Glycyrrhizae has effect of invigorating the spleen and replenishing QI, heat-clearing and toxic substances removing, expelling phlegm for arresting cough, coordinating the actions of various ingredients in a prescription.The selected medicament composing prescription of the present invention, its drug component is through dialectical compatibility, helps using mutual assistant, plays altogether effect of invigorating the spleen and regulating the stomach, clearing heat and expelling damp, promoting blood circulation to remove blood stasis, inducing diuresis for treating stranguria syndrome, promoting the circulation of QI pain relieving, and prostatitic treatment is reached to treating both the principal and secondary aspects of a disease.
The component of the present composition all adopts natural raw material of Chinese medicine, and its preparation is easy, medicine source is wide, cost is low.The present invention follows the prescriptions principle of the traditional Chinese medical science, and various component drug adopt the use that is decocted in water for oral dose.Through clinical practice checking, it is evident in efficacy reliable, and the property of medicine is gentle, does not occur toxic and side effects, and effective percentage reaches 92%, cure rate 72%.
Detailed description of the invention
Below in conjunction with embodiment, the invention will be further described.
Embodiment 1
One is treated prostatitic Chinese medicine composition, and its raw material of Chinese medicine and weight proportion are: Flos Lonicerae 30g, Caulis Akebiae 6g, Herba Polygoni Avicularis 10g, Semen Plantaginis 20g, Herba Dianthi 10g, Fructus Forsythiae 20g, Rhizoma Alismatis 15g, Folium Bambusae 10g, Poria 30g, Cortex Moutan 12g, Radix Salviae Miltiorrhizae 30g, Fructus Gardeniae 15g, Talcum 30g, Rhizoma Corydalis 20g, Radix Angelicae Dahuricae 30g, Radix Paeoniae Rubra 10g, Hedyotidis Diffusae 40g, Herba Scutellariae Barbatae 30g, Radix Glycyrrhizae 6g.
Embodiment 2
One is treated prostatitic Chinese medicine composition, and its raw material of Chinese medicine and weight proportion are: Flos Lonicerae 15g, Caulis Akebiae 10g, Herba Polygoni Avicularis 5g, Semen Plantaginis 25g, Herba Dianthi 12g, Fructus Forsythiae 30g, Rhizoma Alismatis 5g, Folium Bambusae 20g, Poria 10g, Cortex Moutan 20g, Radix Salviae Miltiorrhizae 15g, Fructus Gardeniae 25g, Talcum 10g, Rhizoma Corydalis 30g, Radix Angelicae Dahuricae 15g, Radix Paeoniae Rubra 20g, Hedyotidis Diffusae 25g, Herba Scutellariae Barbatae 40g, Radix Glycyrrhizae 8g.
Embodiment 3
One is treated prostatitic Chinese medicine composition, and its raw material of Chinese medicine and weight proportion are: Flos Lonicerae 25g, Caulis Akebiae 9g, Herba Polygoni Avicularis 15g, Semen Plantaginis 30g, Herba Dianthi 15g, Fructus Forsythiae 10g, Rhizoma Alismatis 20g, Folium Bambusae 12g, Poria 25g, Cortex Moutan 5g, Radix Salviae Miltiorrhizae 25g, Fructus Gardeniae 10g, Talcum 35g, Rhizoma Corydalis 10g, Radix Angelicae Dahuricae 25g, Radix Paeoniae Rubra 15g, Hedyotidis Diffusae 30g, Herba Scutellariae Barbatae 10g, Radix Glycyrrhizae 7g.
Embodiment 4
One is treated prostatitic Chinese medicine composition, and its raw material of Chinese medicine and weight proportion are: Flos Lonicerae 10g, Caulis Akebiae 7g, Herba Polygoni Avicularis 12g, Semen Plantaginis 15g, Herba Dianthi 5g, Fructus Forsythiae 25g, Rhizoma Alismatis 10g, Folium Bambusae 15g, Poria 10g, Cortex Moutan 15g, Radix Salviae Miltiorrhizae 10g, Fructus Gardeniae 20g, Talcum 10g, Rhizoma Corydalis 25g, Radix Angelicae Dahuricae 10g, Radix Paeoniae Rubra 5g, Hedyotidis Diffusae 20g, Herba Scutellariae Barbatae 25g, Radix Glycyrrhizae 5g.
Embodiment 5
One is treated prostatitic Chinese medicine composition, and its raw material of Chinese medicine and weight proportion are: Flos Lonicerae 40g, Caulis Akebiae 5g, Herba Polygoni Avicularis 20g, Semen Plantaginis 10g, Herba Dianthi 20g, Fructus Forsythiae 15g, Rhizoma Alismatis 25g, Folium Bambusae 5g, Poria 40g, Cortex Moutan 10g, Radix Salviae Miltiorrhizae 40g, Fructus Gardeniae 5g, Talcum 40g, Rhizoma Corydalis 15g, Radix Angelicae Dahuricae 40g, Radix Paeoniae Rubra 12g, Hedyotidis Diffusae 50g, Herba Scutellariae Barbatae 15g, Radix Glycyrrhizae 10g.
Chinese medicine composition in embodiment of the present invention decocting method is routinely produced medicament.Concrete grammar is as follows: the raw material of Chinese medicine of prescription is put into container, adds cold water and cover powder, soak 15~20 minutes, then add water and do not have approximately 6 centimetres of powder, decoct for the first time, adopt intense fire to decoct before at a simmer, after boiling with slow fire boiling 20~30 minutes; Decoct for the second time, add water and do not have approximately 4 centimetres of powder, after water boils, decoct 15~20 minutes.Decoct extracting juice twice, merge.
The present invention treats prostatitic Chinese medicine composition with the given one of embodiment 1, does clinical efficacy and is summarized as follows:
One, general data: this Chinese medicine composition is applied to clinical observation case 50 examples, 35~75 years old age.
Two, clinical manifestation:
Frequent micturition, dysurea and urine retention sense, adularescent secretions is discharged from urethra after an action of the bowels or after urinating.Often have testis, spermatic cord, perineum, lumbosacral region pain, pain can emit to Glans penis sometimes.Can be with weak, sexual dysfunction, premature ejaculation sexual impotence or sterile and neurasthenia etc.
Three, usage and dosage: when clinical practice, potion on the one, the about 400ml of twice extracting juice of decocting, point morning, late twice empty stomach decoction being taken warmly.It within six days, is a course for the treatment of.Avoid cold and uncooked food during the treatment thing of pungent stimulation.
Four, criterion of therapeutical effect:
(1) cure: subjective symptoms disappears, it is normal that prostate touch quality is recovered;
(2) effective: transference cure, prostate touch improved texture;
(3) effective: symptom and prostate touch improved texture;
(4) invalid: symptom, sign, prostate touch quality are without improvement.
Five, therapeutic effect: in this clinical observation case, take medicine 2-5 the course for the treatment of, recovery from illness 36 examples, follow up a case by regular visits to and have no recurrence; Effective 7 examples, effective 3 examples, invalid 4 examples.During treatment, there is not toxic and side effects.
Six, model case:
Case 1:
Bao, man, 37 years old.Before half a year, occurred frequent micturition, dysurea and urine retention sense, after urinating, adularescent secretions is discharged from urethra, perineum falling inflation, soreness of the waist and knees, hectic fever night sweat.Examine and see: the few tongue of red tongue, thready and rapid pulse.Be diagnosed as: prostatitis.Take 3 courses for the treatment of of medicament prepared by Chinese medicine composition of the present invention, frequent micturition number of times reduces, and the diseases such as soreness of the waist and knees obviously alleviate; Continue to take 2 courses for the treatment of, all symptoms disappear completely, recovery from illness.After half a year, follow up a case by regular visits to without recurrence.
Case 2:
Soup, man, 49 years old.There is the year before the puckery swelling pain of urine leaching, cramp and pain in the lower abdomen, perineum distending pain, urethral orifice is plucked nebulousurine, and with symptoms such as testis, lumbosacral region pains.Examine and see: yellowish fur, slippery and rapid pulse.Be diagnosed as: prostatitis.Take 3 courses for the treatment of of medicament prepared by Chinese medicine composition of the present invention, all symptoms are eased; Continue to take 2 courses for the treatment of, recovery from illness.After 1 year, follow up a case by regular visits to without recurrence.

Claims (2)

1. the prostatitic Chinese medicine composition for the treatment of, is characterized in that: its raw material of Chinese medicine and weight portion proportioning are: Flos Lonicerae 10-40 part, Caulis Akebiae 5-10 part, Herba Polygoni Avicularis 5-20 part, Semen Plantaginis 10-30 part, Herba Dianthi 5-20 part, Fructus Forsythiae 10-30 part, Rhizoma Alismatis 5-25 part, Folium Bambusae 5-20 part, Poria 10-40 part, Cortex Moutan 5-20 part, Radix Salviae Miltiorrhizae 10-40 part, Fructus Gardeniae 5-25 part, Talcum 10-40 part, Rhizoma Corydalis 10-30 part, Radix Angelicae Dahuricae 10-40 part, Radix Paeoniae Rubra 5-20 part, Hedyotidis Diffusae 20-50 part, Herba Scutellariae Barbatae 10-40 part, Radix Glycyrrhizae 5-10 part.
2. one is treated prostatitic Chinese medicine composition according to claim 1, it is characterized in that: its raw material of Chinese medicine and weight portion proportioning are: 30 parts of Flos Loniceraes, 6 parts of Caulis Akebiaes, 10 parts of Herba Polygoni Avicularis, 20 parts of Semen Plantaginiss, 10 parts of Herba Dianthis, 20 parts of Fructus Forsythiaes, 15 parts of Rhizoma Alismatis, 10 parts, Folium Bambusae, 30 parts of Poria, 12 parts of Cortex Moutans, 30 parts of Radix Salviae Miltiorrhizaes, 15 parts of Fructus Gardeniaes, 30 parts, Talcum, 20 parts of Rhizoma Corydalis, 30 parts of the Radixs Angelicae Dahuricae, 10 parts of Radix Paeoniae Rubra, 40 parts of Hedyotidis Diffusaes, 30 parts of Herba Scutellariae Barbataes, 6 parts, Radix Glycyrrhizae.
CN201410287952.6A 2014-06-25 2014-06-25 Traditional Chinese medicine (TCM) composition for treating prostatitis Pending CN104042957A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201410287952.6A CN104042957A (en) 2014-06-25 2014-06-25 Traditional Chinese medicine (TCM) composition for treating prostatitis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201410287952.6A CN104042957A (en) 2014-06-25 2014-06-25 Traditional Chinese medicine (TCM) composition for treating prostatitis

Publications (1)

Publication Number Publication Date
CN104042957A true CN104042957A (en) 2014-09-17

Family

ID=51496680

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201410287952.6A Pending CN104042957A (en) 2014-06-25 2014-06-25 Traditional Chinese medicine (TCM) composition for treating prostatitis

Country Status (1)

Country Link
CN (1) CN104042957A (en)

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104353034A (en) * 2014-10-24 2015-02-18 葛飞 Chinese medicinal decoction capable of clearing heat and freeing strangury
CN104587256A (en) * 2015-01-25 2015-05-06 董艳丽 Traditional Chinese medicine composition for treating prostatitis
CN104606560A (en) * 2015-02-15 2015-05-13 丁常燕 Traditional-Chinese-medicine composition for treating stranguria
CN105148123A (en) * 2015-07-25 2015-12-16 王军 Traditional Chinese medicinal composition for treating prostatitis
CN105381213A (en) * 2015-09-29 2016-03-09 李素影 Toxin dispelling and stomach nourishing traditional Chinese medicine preparation
CN106362039A (en) * 2016-09-27 2017-02-01 杨巧霞 Traditional Chinese medicine oral liquid for treating scrotum damp caused by dampness-heat in lower energizer
CN110151971A (en) * 2018-07-11 2019-08-23 江苏万可瑞科技实业有限公司 It is a kind of for treating the gel and its production method of male prostatitis
CN113876868A (en) * 2021-10-23 2022-01-04 邓伟 External traditional Chinese medicine ointment for treating prostatitis and preparation method thereof

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101181540A (en) * 2007-11-27 2008-05-21 吉林华康药业股份有限公司 Application of pharmaceutical composition in the preparation of resistance prostatitis
WO2008113118A1 (en) * 2007-03-16 2008-09-25 Medcina Group Pty Ltd Compositions and methods for treating male infertility
CN103656377A (en) * 2013-11-27 2014-03-26 夏毓 Traditional Chinese medicine medicament for internally and externally treating chronic prostatitis

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008113118A1 (en) * 2007-03-16 2008-09-25 Medcina Group Pty Ltd Compositions and methods for treating male infertility
CN101181540A (en) * 2007-11-27 2008-05-21 吉林华康药业股份有限公司 Application of pharmaceutical composition in the preparation of resistance prostatitis
CN103656377A (en) * 2013-11-27 2014-03-26 夏毓 Traditional Chinese medicine medicament for internally and externally treating chronic prostatitis

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
周雄根: "清热活血法治疗急性前列腺炎疗效观察", 《河北中医》 *
曲波等: "施汉章治疗慢性前列腺炎经验", 《山东中医杂志》 *
杨淑霞等: "八正散治热淋的临床应用", 《内蒙古中医药》 *

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104353034A (en) * 2014-10-24 2015-02-18 葛飞 Chinese medicinal decoction capable of clearing heat and freeing strangury
CN104587256A (en) * 2015-01-25 2015-05-06 董艳丽 Traditional Chinese medicine composition for treating prostatitis
CN104606560A (en) * 2015-02-15 2015-05-13 丁常燕 Traditional-Chinese-medicine composition for treating stranguria
CN105148123A (en) * 2015-07-25 2015-12-16 王军 Traditional Chinese medicinal composition for treating prostatitis
CN105381213A (en) * 2015-09-29 2016-03-09 李素影 Toxin dispelling and stomach nourishing traditional Chinese medicine preparation
CN106362039A (en) * 2016-09-27 2017-02-01 杨巧霞 Traditional Chinese medicine oral liquid for treating scrotum damp caused by dampness-heat in lower energizer
CN110151971A (en) * 2018-07-11 2019-08-23 江苏万可瑞科技实业有限公司 It is a kind of for treating the gel and its production method of male prostatitis
CN113876868A (en) * 2021-10-23 2022-01-04 邓伟 External traditional Chinese medicine ointment for treating prostatitis and preparation method thereof

Similar Documents

Publication Publication Date Title
CN104042957A (en) Traditional Chinese medicine (TCM) composition for treating prostatitis
CN103341004B (en) Chinese medicine composition for treating delayed menstrual cycle
CN103463404B (en) Traditional Chinese medicine composition for treating liver and kidney yin deficiency
CN103463528A (en) Traditional Chinese medicine composition for treating chronic eczema
CN102000301A (en) Traditional Chinese medicine composite for treating mammitis and lobular hyperplasia of mammary gland and preparation method thereof
CN103784887A (en) Traditional Chinese medicinal composition for treating kidney deficiency lumbago
CN104043049A (en) Traditional Chinese medicine composition for treating hyperplasia of mammary glands
CN103316295B (en) Traditional Chinese composition for treating rheumatic arthritis
CN104771666A (en) Traditional Chinese medicine composition for treating psoriasis
CN103720996A (en) Traditional Chinese medicinal composition for treating dysmenorrhea
CN103272143B (en) Traditional Chinese medicine composition for treating acne
CN104043087A (en) Traditional Chinese medicine composition for treating Raynaud syndrome
CN104043022A (en) Traditional Chinese medicine composition for treating gynecologic inflammation
CN104043050A (en) Traditional Chinese medicine composition for treating cholecystitis
CN103316298A (en) Traditional Chinese composition for treating arthralgia
CN101269157B (en) Method for preparing wine for warming meridian, removing paralysism, releasing tendon, activating collaterals to relieve pain
CN104173856A (en) Traditional Chinese medicine composition for treating morbid leukorrhea
CN104173565A (en) Traditional Chinese medicine composition for treating irregular menstruation
CN104043010A (en) Traditional Chinese medicine (TCM) composition for treating prostatitis
CN104888134A (en) Traditional Chinese medicine composition for treatment of haemorrhoids
CN103705870A (en) Traditional Chinese medicine composition for treating mastitis
CN104606624A (en) Traditional-Chinese-medicine composition for treating dampness and heat of liver and gallbladder
CN103705783A (en) Traditional Chinese medicine composition for treating frequent urination, urgent urination and painful urination caused by hyperplasia of prostate
CN103705684A (en) Traditional Chinese medicine composition for treating stranguria
CN104587256A (en) Traditional Chinese medicine composition for treating prostatitis

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication
RJ01 Rejection of invention patent application after publication

Application publication date: 20140917